Investment Q&A

Q: I have a position in mre- t which has gone soft over the last month? Any reason for it? Has there been any insider buying during the weakness? Could this be considered a play on the EV space?

Q: MRS announced the formation of a New Advisory Committee. Looks like an experienced team. Do you view this as positive? Contracts have been slow to come in but maybe they are spending the team putting the pieces in place to support the growth they see ahead.

Q: could you give an opinion re the future of this company. just opened the new plant and things should be positive but the stock has gone south in the last few weeks.
with all the excitement re plant protein this stock should be going up

Q: Please list your top 5 Canadian companies with a market cap under 250 million. Looking for potential 10 baggers over the next 5 years. Also, a brief description of why you like the company.
Thanks
Rob

Q: Bought SZLS on a whim. Has been tracking downward since. Any potential going forward? Thanks...

Q: Thoughts on this company? Revenue growth? Insider ownership?

Q: This stock, CTS -- has been a good pick. Thanks! How much room do you see on the upside this year?

Q: Hi Team,
I was contemplating selling mitk and replacing it with Med. I am currently heavy in tech, but am investing for long term. Which of these 2 stocks do you see having more potential upside over the next few years? Thanks
Shane

Q: Has been on a slow steady decline since highs in April. Is there anything to be concerned with? also is there something else you might recommend in speculative/ small cap?
Thanks

Q: Could you please give me four small cap stocks to put in a TFSA taking into account my high risk profile. Could you also rank them with your top pick first knowing you do not favor these type of stocks

Q: What is your opinion on EVGO, it came out as an SPAC?

Q: It has been awhile that a question has been asked about this company.

It has been breaking out technically.

Can you provide a fundamental update of this company. How does the future look for this company and do you have any opinion on the c-suite here.

Would you recommend for a TFSA?

Thanks for all you do!!!

Q: Small, unfollowed company with insider buying. Your thoughts?

John

Q: UEX is moving. It was 50 cents not too long ago and in about a month it dropped to 38 cents today. Can you please provide me with the most accurate website depicting the live price for uranium?What do you think about the future of this company and the supply and demand of uranium. You think UEX and uranium spot price will move alot over the summer? Or will it drop quickly over the summer?

Q: what are your thoughts on POET tech today
Thank You
Peter

Q: What exactly is holding Surge back from participating in rising oil prices? You would think their debt load and hedges and perhaps just the entire oil industry being out of favour are so yesterdays news. Looking forward for Surge, do you still see a viable company?

Q: July 2nd I asked if NEXE was a buy sell or hold . your reply ,was that you do not give that type advice. you did not give that same answer today about a similar question regarding STOR why??????? I will ask in a different way ___ my break even price on NEXE is 1.37 other sites have said this will go to .92 cents is this 5i opinion; is this worth keeping in hope that their wrong

Q: Hello. I started a new position in BRAG in Jan, 2021 and I am down 47% to date. Is this a good time to add or should I wait a little longer?

Q: Gritstone Bio (GRTS) is a small, early-stage biotech company to which Gilead Sciences has provided some funding under an agreement announced on Feb 1, 2021:

"Under the terms of the agreement, Gilead will make a $60 million payment at closing, consisting of a $30 million upfront cash payment and a $30 million equity investment at a premium. Gilead will be responsible for conducting a Phase 1 study for the HIV-specific therapeutic vaccine and holds an exclusive option under the collaboration to obtain an exclusive license to develop and commercialize the HIV-specific therapeutic vaccine beyond Phase 1. Gritstone is also eligible to receive up to an additional $725 million if the option is exercised and if certain clinical, regulatory and commercial milestones are achieved, as well as mid single-digit to low double-digit tiered royalties on net sales upon commercialization."

GRTS share price has established a baseline after falling steadily since the funding announcement. Presumably Gilead did some due diligence before investing its own money, but the stock price could go to zero if Gilead walks away. However, it could also soar if the trials are successful. Would you consider GRTS to be a worthwhile speculative buy? What has been your experience of investing in early-stage biotech companies that have drawn the attention of Big Pharma?

Q: What do you think of the mid to long term growth of POOL and SPWH?